Disclosures for "Single Trajectory Dual Targeting of Subthalamic Nucleus and Ventral Intermedius Thalamic Nucleus in Patients with Severe Tremor-Predominant Parkinson's Disease")
-
Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adamas. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Evidente has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Evidente has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ipsen. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. The institution of Dr. Evidente has received research support from Sunovion. The institution of Dr. Evidente has received research support from Pharma 2B. The institution of Dr. Evidente has received research support from Neuraly. The institution of Dr. Evidente has received research support from Revance. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Lundbeck. The institution of Dr. Evidente has received research support from Abbvie. The institution of Dr. Evidente has received research support from Acadia. The institution of Dr. Evidente has received research support from Aptinyx.
-
Dr. Ponce has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Ponce has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Ponce has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
-
Miss Evidente has nothing to disclose.
-
Dr. Garrett has nothing to disclose.
-
Miss Evidente has nothing to disclose.